Westbourne Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.34M | Buy |
10,461
+200
| +2% | +$23.4K | 0.37% | 44 |
|
|
2026
Q1 | $1.23M | Sell |
10,261
-125
| -1% | -$14.4K | 0.36% | 46 |
|
|
2025
Q4 | $1.09M | Buy |
10,386
+10
| +0.1% | +$939 | 0.3% | 47 |
|
|
2025
Q3 | $871K | Sell |
10,376
-35
| -0.3% | -$2.88K | 0.24% | 61 |
|
|
2025
Q2 | $824K | Buy |
10,411
+1,850
| +22% | +$147K | 0.25% | 61 |
|
|
2025
Q1 | $768K | Buy |
8,561
+40
| +0.5% | +$3.73K | 0.27% | 54 |
|
|
2024
Q4 | $848K | Hold |
8,521
| – | – | 0.29% | 51 |
|
|
2024
Q3 | $968K | Buy |
8,521
+96
| +1% | +$11.4K | 0.34% | 49 |
|
|
2024
Q2 | $1.04M | Hold |
8,425
| – | – | 0.38% | 47 |
|
|
2024
Q1 | $1.11M | Sell |
8,425
-50
| -0.6% | -$6.16K | 0.41% | 47 |
|
|
2023
Q4 | $924K | Buy |
8,475
+259
| +3% | +$26.9K | 0.37% | 48 |
|
|
2023
Q3 | $846K | Hold |
8,216
| – | – | 0.39% | 47 |
|
|
2023
Q2 | $948K | Sell |
8,216
-119
| -1% | -$13.5K | 0.42% | 48 |
|
|
2023
Q1 | $887K | Sell |
8,335
-550
| -6% | -$59.4K | 0.43% | 49 |
|
|
2022
Q4 | $986K | Sell |
8,885
-700
| -7% | -$71.6K | 0.5% | 49 |
|
|
2022
Q3 | $825K | Buy |
9,585
+800
| +9% | +$71.4K | 0.44% | 52 |
|
|
2022
Q2 | $801K | Sell |
8,785
-25
| -0.3% | -$2.22K | 0.5% | 46 |
|
|
2022
Q1 | $723K | Hold |
8,810
| – | – | 0.3% | 56 |
|
|
2021
Q4 | $675K | Buy |
+8,810
| New | +$702K | 0.27% | 61 |
|
|
2021
Q3 | – | Sell |
-2,645
| Closed | -$206K | – | 85 |
|
|
2021
Q2 | $206K | Sell |
2,645
-562
| -18% | -$41.8K | 0.09% | 83 |
|
|
2021
Q1 | $236K | Buy |
+3,207
| New | +$237K | 0.12% | 78 |
|
|
2018
Q2 | – | Sell |
-17,727
| Closed | -$921K | – | 95 |
|
|
2018
Q1 | $921K | Sell |
17,727
-2,562
| -13% | -$138K | 0.74% | 48 |
|
|
2017
Q4 | $1.09M | Buy |
20,289
+482
| +2% | +$26.7K | 0.83% | 43 |
|
|
2017
Q3 | $1.21M | Sell |
19,807
-734
| -4% | -$44.5K | 0.94% | 36 |
|
|
2017
Q2 | $1.26M | Sell |
20,541
-1,488
| -7% | -$90.6K | 1.02% | 33 |
|
|
2017
Q1 | $1.34M | Sell |
22,029
-341
| -2% | -$20.7K | 1.1% | 28 |
|
|
2016
Q4 | $1.26M | Hold |
22,370
| – | – | 1.1% | 29 |
|
|
2016
Q3 | $1.33M | Sell |
22,370
-1,252
| -5% | -$73.2K | 1.18% | 28 |
|
|
2016
Q2 | $1.3M | Sell |
23,622
-775
| -3% | -$41.2K | 1.17% | 27 |
|
|
2016
Q1 | $1.23M | Buy |
24,397
+4,281
| +21% | +$210K | 1.18% | 28 |
|
|
2015
Q4 | $1.01M | Sell |
20,116
-289
| -1% | -$14.6K | 0.98% | 36 |
|
|
2015
Q3 | $962K | Sell |
20,405
-2,724
| -12% | -$145K | 0.97% | 30 |
|
|
2015
Q2 | $1.26M | Buy |
+23,129
| New | +$1.3M | 1.14% | 29 |
|
Other funds holding MRK
ECSS
Westbourne Investment Advisors's MRK Position: Q2 2026 in Review
Westbourne Investment Advisors increased its Merck (MRK) stake by 1.9% in Q2 2026, buying an estimated $23.4K and bringing the position to 10,461 shares worth $1.34M. The position accounts for 0.37% of the portfolio, ranked #44.
Westbourne Investment Advisors first reported a position in MRK in Q2 2015 and has held it in 33 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Westbourne Investment Advisors held 10,461 shares of Merck worth $1.34M as of Q2 2026.
- Westbourne Investment Advisors bought 200 Merck shares in Q2 2026, an estimated $23.4K.
- Merck made up 0.37% of Westbourne Investment Advisors's portfolio in Q2 2026, its #44 holding.
- Westbourne Investment Advisors first reported a position in Merck in Q2 2015 and has held it in 33 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Westbourne Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.